NCT03557905 (RM) is a NA clinical trial of RM 0.5 in Intraoperative Complications, sponsored by Assiut University.

Who is sponsoring NCT03557905?

NCT03557905 is sponsored by Assiut University.

What drugs are being tested in NCT03557905?

Interventions in NCT03557905: RM 0.5, RM 0.3.

What condition does NCT03557905 study?

NCT03557905 studies Intraoperative Complications.

Is NCT03557905 still recruiting?

NCT03557905 is currently completed. Last updated 25 July 2023.

Last reviewed 2023-07-25 · How we verify

NCT03557905: RM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasonographic Assessment of Lung Recruitment Maneuvers in Children Undergoing Lengthy Microsurgery Operations

Completed NA Last updated 25 July 2023

What this trial tests

NA trial testing RM 0.5 in Intraoperative Complications in 44 participants. Completed in 30 January 2023.

Timeline

6 August 2018

Primary endpoint
30 January 2023

30 January 2023

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	44
Start date	6 August 2018
Primary completion	30 January 2023
Estimated completion	30 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

RM 0.5
RM 0.3

Conditions studied

Intraoperative Complications — all drugs for Intraoperative Complications →

Sponsor

Assiut University

Who can join

Adults 2 to 12, any sex, with Intraoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to explore the clinical value of ultrasonic monitoring in the diagnosis of anesthesia-induced atelectasis, the assessment of the effects of lung recruitment, the best positive end-expiratory pressure (PEEP) after RM and in the detection of the point of lung re-collapse after RM in pediatric patients undergoing lengthy microsurgery operations using two levels of intraoperative FIO2 (0.5 VERSUS 0.3).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intraoperative Complications

Currently open trials in the same condition.

NCT07390903 — GLS in Difficult CPB Weaning · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03557905 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 25 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03557905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing